Global Genome Editing Market 2024-2028

Global Genome Editing Market 2024-2028


The genome editing market is forecasted to grow by USD 7.23 bn during 2023-2028, accelerating at a CAGR of 15.88% during the forecast period. The report on the genome editing market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rapid technological advancements in genome editing, increasing demand for personalized medicine, and the emergence of novel gene editing platforms.

Technavio's genome editing market is segmented as below:

By End-user
  • Pharmaceutical and biotechnology companies
  • Academic institutes and research laboratories
  • CRO
By Delivery Mode
  • Ex-vivo
  • In-vivo
By Geographical Landscape
  • North America
  • Europe
  • Asia
  • Rest of World (ROW)
This study identifies the rise of CRISPR-based diagnostics as one of the prime reasons driving the genome editing market growth during the next few years. Also, the growing integration of gene editing with AI and data analytics and increasing adoption of genome editing in agriculture and livestock will lead to sizable demand in the market.

The report on the genome editing market covers the following areas:
  • Genome editing market sizing
  • Genome editing market forecast
  • Genome editing market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading genome editing market vendors that include AstraZeneca PLC, Caribou Biosciences Inc., Cellectis SA, Cibus, Danaher Corp., Editas Medicine Inc., Egenesis, GenScript Biotech Corp., Horizon Discovery Ltd., Intellia Therapeutics Inc., Lonza Group Ltd., Merck KGaA, New England Biolabs Inc., OriGene Technologies Inc., PerkinElmer Inc, Precision BioSciences Inc., Sangamo Therapeutics Inc., Takara Bio Inc., Tecan Trading AG, and Thermo Fisher Scientific Inc.. Also, the genome editing market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources through an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.


1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by End-user
Exhibit 06: Executive Summary - Chart on Market Segmentation by Delivery Mode
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
4.1 Global genome editing market 2018 - 2022
Exhibit 18: Historic Market Size - Data Table on global genome editing market 2018 - 2022 ($ billion)
4.2 End-user Segment Analysis 2018 - 2022
Exhibit 19: Historic Market Size - End-user Segment 2018 - 2022 ($ billion)
4.3 Delivery mode Segment Analysis 2018 - 2022
Exhibit 20: Historic Market Size - Delivery mode Segment 2018 - 2022 ($ billion)
4.4 Geography Segment Analysis 2018 - 2022
Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
4.5 Country Segment Analysis 2018 - 2022
Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
5 Five Forces Analysis
5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by End-user
6.1 Market segments
Exhibit 30: Chart on End-user - Market share 2023-2028 (%)
Exhibit 31: Data Table on End-user - Market share 2023-2028 (%)
6.2 Comparison by End-user
Exhibit 32: Chart on Comparison by End-user
Exhibit 33: Data Table on Comparison by End-user
6.3 Pharmaceutical and biotechnology companies - Market size and forecast 2023-2028
Exhibit 34: Chart on Pharmaceutical and biotechnology companies - Market size and forecast 2023-2028 ($ billion)
Exhibit 35: Data Table on Pharmaceutical and biotechnology companies - Market size and forecast 2023-2028 ($ billion)
Exhibit 36: Chart on Pharmaceutical and biotechnology companies - Year-over-year growth 2023-2028 (%)
Exhibit 37: Data Table on Pharmaceutical and biotechnology companies - Year-over-year growth 2023-2028 (%)
6.4 Academic institutes and research laboratories - Market size and forecast 2023-2028
Exhibit 38: Chart on Academic institutes and research laboratories - Market size and forecast 2023-2028 ($ billion)
Exhibit 39: Data Table on Academic institutes and research laboratories - Market size and forecast 2023-2028 ($ billion)
Exhibit 40: Chart on Academic institutes and research laboratories - Year-over-year growth 2023-2028 (%)
Exhibit 41: Data Table on Academic institutes and research laboratories - Year-over-year growth 2023-2028 (%)
6.5 CRO - Market size and forecast 2023-2028
Exhibit 42: Chart on CRO - Market size and forecast 2023-2028 ($ billion)
Exhibit 43: Data Table on CRO - Market size and forecast 2023-2028 ($ billion)
Exhibit 44: Chart on CRO - Year-over-year growth 2023-2028 (%)
Exhibit 45: Data Table on CRO - Year-over-year growth 2023-2028 (%)
6.6 Market opportunity by End-user
Exhibit 46: Market opportunity by End-user ($ billion)
Exhibit 47: Data Table on Market opportunity by End-user ($ billion)
7 Market Segmentation by Delivery Mode
7.1 Market segments
Exhibit 48: Chart on Delivery Mode - Market share 2023-2028 (%)
Exhibit 49: Data Table on Delivery Mode - Market share 2023-2028 (%)
7.2 Comparison by Delivery Mode
Exhibit 50: Chart on Comparison by Delivery Mode
Exhibit 51: Data Table on Comparison by Delivery Mode
7.3 Ex-vivo - Market size and forecast 2023-2028
Exhibit 52: Chart on Ex-vivo - Market size and forecast 2023-2028 ($ billion)
Exhibit 53: Data Table on Ex-vivo - Market size and forecast 2023-2028 ($ billion)
Exhibit 54: Chart on Ex-vivo - Year-over-year growth 2023-2028 (%)
Exhibit 55: Data Table on Ex-vivo - Year-over-year growth 2023-2028 (%)
7.4 In-vivo - Market size and forecast 2023-2028
Exhibit 56: Chart on In-vivo - Market size and forecast 2023-2028 ($ billion)
Exhibit 57: Data Table on In-vivo - Market size and forecast 2023-2028 ($ billion)
Exhibit 58: Chart on In-vivo - Year-over-year growth 2023-2028 (%)
Exhibit 59: Data Table on In-vivo - Year-over-year growth 2023-2028 (%)
7.5 Market opportunity by Delivery Mode
Exhibit 60: Market opportunity by Delivery Mode ($ billion)
Exhibit 61: Data Table on Market opportunity by Delivery Mode ($ billion)
8 Customer Landscape
8.1 Customer landscape overview
Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
9.1 Geographic segmentation
Exhibit 63: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibit 64: Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
Exhibit 65: Chart on Geographic comparison
Exhibit 66: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Exhibit 67: Chart on North America - Market size and forecast 2023-2028 ($ billion)
Exhibit 68: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Exhibit 69: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibit 70: Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Exhibit 71: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibit 72: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibit 73: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibit 74: Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Exhibit 75: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibit 76: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibit 77: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibit 78: Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Exhibit 83: Chart on US - Market size and forecast 2023-2028 ($ billion)
Exhibit 84: Data Table on US - Market size and forecast 2023-2028 ($ billion)
Exhibit 85: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibit 86: Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 UK - Market size and forecast 2023-2028
Exhibit 87: Chart on UK - Market size and forecast 2023-2028 ($ billion)
Exhibit 88: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
Exhibit 89: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibit 90: Data Table on UK - Year-over-year growth 2023-2028 (%)
9.9 Germany - Market size and forecast 2023-2028
Exhibit 91: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibit 92: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibit 93: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibit 94: Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.10 Canada - Market size and forecast 2023-2028
Exhibit 95: Chart on Canada - Market size and forecast 2023-2028 ($ billion)
Exhibit 96: Data Table on Canada - Market size and forecast 2023-2028 ($ billion)
Exhibit 97: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibit 98: Data Table on Canada - Year-over-year growth 2023-2028 (%)
9.11 China - Market size and forecast 2023-2028
Exhibit 99: Chart on China - Market size and forecast 2023-2028 ($ billion)
Exhibit 100: Data Table on China - Market size and forecast 2023-2028 ($ billion)
Exhibit 101: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibit 102: Data Table on China - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 103: Market opportunity By Geographical Landscape ($ billion)
Exhibit 104: Data Tables on Market opportunity By Geographical Landscape ($ billion)
10 Drivers, Challenges, and Trends
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 105: Impact of drivers and challenges in 2023 and 2028
10.4 Market trends
11 Vendor Landscape
11.1 Overview
11.2 Vendor landscape
Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 107: Overview on factors of disruption
11.4 Industry risks
Exhibit 108: Impact of key risks on business
12 Vendor Analysis
12.1 Vendors covered
Exhibit 109: Vendors covered
12.2 Market positioning of vendors
Exhibit 110: Matrix on vendor position and classification
12.3 AstraZeneca PLC
Exhibit 111: AstraZeneca PLC - Overview
Exhibit 112: AstraZeneca PLC - Product / Service
Exhibit 113: AstraZeneca PLC - Key news
Exhibit 114: AstraZeneca PLC - Key offerings
12.4 Caribou Biosciences Inc.
Exhibit 115: Caribou Biosciences Inc. - Overview
Exhibit 116: Caribou Biosciences Inc. - Product / Service
Exhibit 117: Caribou Biosciences Inc. - Key offerings
12.5 Cellectis SA
Exhibit 118: Cellectis SA - Overview
Exhibit 119: Cellectis SA - Product / Service
Exhibit 120: Cellectis SA - Key offerings
12.6 Cibus
Exhibit 121: Cibus - Overview
Exhibit 122: Cibus - Product / Service
Exhibit 123: Cibus - Key offerings
12.7 Danaher Corp.
Exhibit 124: Danaher Corp. - Overview
Exhibit 125: Danaher Corp. - Business segments
Exhibit 126: Danaher Corp. - Key news
Exhibit 127: Danaher Corp. - Key offerings
Exhibit 128: Danaher Corp. - Segment focus
12.8 Editas Medicine Inc.
Exhibit 129: Editas Medicine Inc. - Overview
Exhibit 130: Editas Medicine Inc. - Product / Service
Exhibit 131: Editas Medicine Inc. - Key offerings
12.9 Egenesis
Exhibit 132: Egenesis - Overview
Exhibit 133: Egenesis - Product / Service
Exhibit 134: Egenesis - Key offerings
12.10 GenScript Biotech Corp.
Exhibit 135: GenScript Biotech Corp. - Overview
Exhibit 136: GenScript Biotech Corp. - Business segments
Exhibit 137: GenScript Biotech Corp. - Key offerings
Exhibit 138: GenScript Biotech Corp. - Segment focus
12.11 Horizon Discovery Ltd.
Exhibit 139: Horizon Discovery Ltd. - Overview
Exhibit 140: Horizon Discovery Ltd. - Business segments
Exhibit 141: Horizon Discovery Ltd. - Key offerings
Exhibit 142: Horizon Discovery Ltd. - Segment focus
12.12 Intellia Therapeutics Inc.
Exhibit 143: Intellia Therapeutics Inc. - Overview
Exhibit 144: Intellia Therapeutics Inc. - Product / Service
Exhibit 145: Intellia Therapeutics Inc. - Key offerings
12.13 Merck KGaA
Exhibit 146: Merck KGaA - Overview
Exhibit 147: Merck KGaA - Business segments
Exhibit 148: Merck KGaA - Key news
Exhibit 149: Merck KGaA - Key offerings
Exhibit 150: Merck KGaA - Segment focus
12.14 New England Biolabs Inc.
Exhibit 151: New England Biolabs Inc. - Overview
Exhibit 152: New England Biolabs Inc. - Product / Service
Exhibit 153: New England Biolabs Inc. - Key news
Exhibit 154: New England Biolabs Inc. - Key offerings
12.15 Precision BioSciences Inc.
Exhibit 155: Precision BioSciences Inc. - Overview
Exhibit 156: Precision BioSciences Inc. - Business segments
Exhibit 157: Precision BioSciences Inc. - Key offerings
Exhibit 158: Precision BioSciences Inc. - Segment focus
12.16 Sangamo Therapeutics Inc.
Exhibit 159: Sangamo Therapeutics Inc. - Overview
Exhibit 160: Sangamo Therapeutics Inc. - Product / Service
Exhibit 161: Sangamo Therapeutics Inc. - Key offerings
12.17 Takara Bio Inc.
Exhibit 162: Takara Bio Inc. - Overview
Exhibit 163: Takara Bio Inc. - Business segments
Exhibit 164: Takara Bio Inc. - Key offerings
Exhibit 165: Takara Bio Inc. - Segment focus
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 166: Inclusions checklist
Exhibit 167: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 168: Currency conversion rates for US$
13.4 Research methodology
Exhibit 169: Research methodology
Exhibit 170: Validation techniques employed for market sizing
Exhibit 171: Information sources
13.5 List of abbreviations
Exhibit 172: List of abbreviations
Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by End-user
Exhibits6: Executive Summary - Chart on Market Segmentation by Delivery Mode
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits18: Historic Market Size - Data Table on global genome editing market 2018 - 2022 ($ billion)
Exhibits19: Historic Market Size - End-user Segment 2018 - 2022 ($ billion)
Exhibits20: Historic Market Size - Delivery mode Segment 2018 - 2022 ($ billion)
Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)
Exhibits23: Five forces analysis - Comparison between 2023 and 2028
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits29: Chart on Market condition - Five forces 2023 and 2028
Exhibits30: Chart on End-user - Market share 2023-2028 (%)
Exhibits31: Data Table on End-user - Market share 2023-2028 (%)
Exhibits32: Chart on Comparison by End-user
Exhibits33: Data Table on Comparison by End-user
Exhibits34: Chart on Pharmaceutical and biotechnology companies - Market size and forecast 2023-2028 ($ billion)
Exhibits35: Data Table on Pharmaceutical and biotechnology companies - Market size and forecast 2023-2028 ($ billion)
Exhibits36: Chart on Pharmaceutical and biotechnology companies - Year-over-year growth 2023-2028 (%)
Exhibits37: Data Table on Pharmaceutical and biotechnology companies - Year-over-year growth 2023-2028 (%)
Exhibits38: Chart on Academic institutes and research laboratories - Market size and forecast 2023-2028 ($ billion)
Exhibits39: Data Table on Academic institutes and research laboratories - Market size and forecast 2023-2028 ($ billion)
Exhibits40: Chart on Academic institutes and research laboratories - Year-over-year growth 2023-2028 (%)
Exhibits41: Data Table on Academic institutes and research laboratories - Year-over-year growth 2023-2028 (%)
Exhibits42: Chart on CRO - Market size and forecast 2023-2028 ($ billion)
Exhibits43: Data Table on CRO - Market size and forecast 2023-2028 ($ billion)
Exhibits44: Chart on CRO - Year-over-year growth 2023-2028 (%)
Exhibits45: Data Table on CRO - Year-over-year growth 2023-2028 (%)
Exhibits46: Market opportunity by End-user ($ billion)
Exhibits47: Data Table on Market opportunity by End-user ($ billion)
Exhibits48: Chart on Delivery Mode - Market share 2023-2028 (%)
Exhibits49: Data Table on Delivery Mode - Market share 2023-2028 (%)
Exhibits50: Chart on Comparison by Delivery Mode
Exhibits51: Data Table on Comparison by Delivery Mode
Exhibits52: Chart on Ex-vivo - Market size and forecast 2023-2028 ($ billion)
Exhibits53: Data Table on Ex-vivo - Market size and forecast 2023-2028 ($ billion)
Exhibits54: Chart on Ex-vivo - Year-over-year growth 2023-2028 (%)
Exhibits55: Data Table on Ex-vivo - Year-over-year growth 2023-2028 (%)
Exhibits56: Chart on In-vivo - Market size and forecast 2023-2028 ($ billion)
Exhibits57: Data Table on In-vivo - Market size and forecast 2023-2028 ($ billion)
Exhibits58: Chart on In-vivo - Year-over-year growth 2023-2028 (%)
Exhibits59: Data Table on In-vivo - Year-over-year growth 2023-2028 (%)
Exhibits60: Market opportunity by Delivery Mode ($ billion)
Exhibits61: Data Table on Market opportunity by Delivery Mode ($ billion)
Exhibits62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits63: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits64: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits65: Chart on Geographic comparison
Exhibits66: Data Table on Geographic comparison
Exhibits67: Chart on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits68: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Exhibits69: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits70: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits71: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits72: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibits73: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits74: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits75: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits76: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibits77: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits78: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibits81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits83: Chart on US - Market size and forecast 2023-2028 ($ billion)
Exhibits84: Data Table on US - Market size and forecast 2023-2028 ($ billion)
Exhibits85: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits86: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits87: Chart on UK - Market size and forecast 2023-2028 ($ billion)
Exhibits88: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
Exhibits89: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits90: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits91: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits92: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibits93: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits94: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits95: Chart on Canada - Market size and forecast 2023-2028 ($ billion)
Exhibits96: Data Table on Canada - Market size and forecast 2023-2028 ($ billion)
Exhibits97: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibits98: Data Table on Canada - Year-over-year growth 2023-2028 (%)
Exhibits99: Chart on China - Market size and forecast 2023-2028 ($ billion)
Exhibits100: Data Table on China - Market size and forecast 2023-2028 ($ billion)
Exhibits101: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits102: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits103: Market opportunity By Geographical Landscape ($ billion)
Exhibits104: Data Tables on Market opportunity By Geographical Landscape ($ billion)
Exhibits105: Impact of drivers and challenges in 2023 and 2028
Exhibits106: Overview on Criticality of inputs and Factors of differentiation
Exhibits107: Overview on factors of disruption
Exhibits108: Impact of key risks on business
Exhibits109: Vendors covered
Exhibits110: Matrix on vendor position and classification
Exhibits111: AstraZeneca PLC - Overview
Exhibits112: AstraZeneca PLC - Product / Service
Exhibits113: AstraZeneca PLC - Key news
Exhibits114: AstraZeneca PLC - Key offerings
Exhibits115: Caribou Biosciences Inc. - Overview
Exhibits116: Caribou Biosciences Inc. - Product / Service
Exhibits117: Caribou Biosciences Inc. - Key offerings
Exhibits118: Cellectis SA - Overview
Exhibits119: Cellectis SA - Product / Service
Exhibits120: Cellectis SA - Key offerings
Exhibits121: Cibus - Overview
Exhibits122: Cibus - Product / Service
Exhibits123: Cibus - Key offerings
Exhibits124: Danaher Corp. - Overview
Exhibits125: Danaher Corp. - Business segments
Exhibits126: Danaher Corp. - Key news
Exhibits127: Danaher Corp. - Key offerings
Exhibits128: Danaher Corp. - Segment focus
Exhibits129: Editas Medicine Inc. - Overview
Exhibits130: Editas Medicine Inc. - Product / Service
Exhibits131: Editas Medicine Inc. - Key offerings
Exhibits132: Egenesis - Overview
Exhibits133: Egenesis - Product / Service
Exhibits134: Egenesis - Key offerings
Exhibits135: GenScript Biotech Corp. - Overview
Exhibits136: GenScript Biotech Corp. - Business segments
Exhibits137: GenScript Biotech Corp. - Key offerings
Exhibits138: GenScript Biotech Corp. - Segment focus
Exhibits139: Horizon Discovery Ltd. - Overview
Exhibits140: Horizon Discovery Ltd. - Business segments
Exhibits141: Horizon Discovery Ltd. - Key offerings
Exhibits142: Horizon Discovery Ltd. - Segment focus
Exhibits143: Intellia Therapeutics Inc. - Overview
Exhibits144: Intellia Therapeutics Inc. - Product / Service
Exhibits145: Intellia Therapeutics Inc. - Key offerings
Exhibits146: Merck KGaA - Overview
Exhibits147: Merck KGaA - Business segments
Exhibits148: Merck KGaA - Key news
Exhibits149: Merck KGaA - Key offerings
Exhibits150: Merck KGaA - Segment focus
Exhibits151: New England Biolabs Inc. - Overview
Exhibits152: New England Biolabs Inc. - Product / Service
Exhibits153: New England Biolabs Inc. - Key news
Exhibits154: New England Biolabs Inc. - Key offerings
Exhibits155: Precision BioSciences Inc. - Overview
Exhibits156: Precision BioSciences Inc. - Business segments
Exhibits157: Precision BioSciences Inc. - Key offerings
Exhibits158: Precision BioSciences Inc. - Segment focus
Exhibits159: Sangamo Therapeutics Inc. - Overview
Exhibits160: Sangamo Therapeutics Inc. - Product / Service
Exhibits161: Sangamo Therapeutics Inc. - Key offerings
Exhibits162: Takara Bio Inc. - Overview
Exhibits163: Takara Bio Inc. - Business segments
Exhibits164: Takara Bio Inc. - Key offerings
Exhibits165: Takara Bio Inc. - Segment focus
Exhibits166: Inclusions checklist
Exhibits167: Exclusions checklist
Exhibits168: Currency conversion rates for US$
Exhibits169: Research methodology
Exhibits170: Validation techniques employed for market sizing
Exhibits171: Information sources
Exhibits172: List of abbreviations

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings